NeuroFlow Stock

NeuroFlow is a HIPAA compliant digital health platform that optimizes the way behavioral healthcare is delivered, tracked, and assessed.

Sign up today and learn more about NeuroFlow Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About NeuroFlow Stock

NeuroFlow is a platform to be a resource and asset to healthcare providers in their pursuit to get patients better and improve lives. It is a cloud-based platform that empowers healthcare providers to track, assess, and engage patients using evidence-based practices to support their mental health. The suite of tools supports remote monitoring and behavioral health integration across the continuum of care, including psychology, primary care, and pain management settings, to increase patient engagement and improve compliance.


Magellan Health Services

Click Therapeutics, NeuroFlow

Funding History

October 2017$1.3M
July 2018$225K
September 2018$2.3M
December 2019$7.5M
April 2020$749K
January 2021$20.0M
September 2022$750K
October 2022$25.0M


CEO & Co-Founder

Christopher Molaro

COO & Co-Founder

Adam Pardes

Director & Health Plan Sales

David Santivasci

VP of Sales

Neal Smart

Chief Product Officer

Julia Kastner

Advisory Board Member

Carl Buhler

Member Board Of Directors

Mark McAdoo


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: